Perfluorochemicals and Photodynamic Therapy in Mice

  • M. C. Berenbaum
  • S. L. Akande
  • F. H. Armstrong
  • P. K. Bentley
  • R. Bonnett
  • R. D. White
  • K. C. Lowe
Chapter
Part of the Advances in Experimental Medicine and Biology book series (AEMB, volume 277)

Abstract

Photodynamic therapy (PDT) is currently being evaluated for the treatment of tumours in man. It depends on the use of tumour-localising porphyrins that are activated by visible light to produce tumour destruction (Fingar et al., 1988). PDT is oxygen dependent and recent attention has focussed on strategies for improving tumour oxygenation and thereby increasing the effectiveness of PDT.

Keywords

Photodynamic Therapy Evans Blue Copper Vapour Laser Tumour Oxygenation Advanced Squamous Cell Carcinoma 
These keywords were added by machine and not by the authors. This process is experimental and the keywords may be updated as the learning algorithm improves.
This is a preview of subscription content, log in to check access.

Preview

Unable to display preview. Download preview PDF.

Unable to display preview. Download preview PDF.

References

  1. Berenbaum, M.C., Akande, S.L., Bonnett, R., Kaur, H., Ioannou, S., White, R.D and Winfield, U.-J., 1986, Meso-tetra(hydroxyphenyl)-porphyrins, a new class of potent tumour photosensitizers with favourable selectivity. Br. J. Cancer, 54.: 717.PubMedCrossRefGoogle Scholar
  2. Fingar, V.H., Mang, T.S. and Henderson, B.W., 1988, Modification of photodynamic therapy-induced hypoxia by Fluosol-DA (20%) and carbogen breathing in mice. Cancer Res., 48: 3350.PubMedGoogle Scholar
  3. Lee, I., Levitt, S.H. and Song, C.W., 1987, Effects of Fluosol-DA 20% and carbogen on the radioresponse of SCK tumors and skin of A/J mice. Radiat. Res., 112: 173.PubMedCrossRefGoogle Scholar
  4. Lowe, K.C., 1987, Perfluorocarbons as oxygen-transport fluids. Comp. Biochem. Physiol., 87A: 825.CrossRefGoogle Scholar
  5. Lowe, K.C., 1988, Biological assessment of perfluorochemical emulsions, in: “Blood Substitutes: Preparation, Physiology and Medical Applications”, K.C. Lowe, ed., p. 149, Ellis Horwood, Chichester.Google Scholar
  6. Lowe, K.C. and Bollands, A.D., 1985, Physiological effects of perfluorocarbon blood substitutes. Med. Lab. Sci., 42: 367.PubMedGoogle Scholar
  7. Lustig, R.A., Rose, C.M. and McIntosh-Lowe, N.L., 1988, Fluosol-DA and oxygen as an adjuvant to the radiotherapeutic management of advanced head/neck carcinoma. Biomat. Art. Cells Art. Org., 16: 511.Google Scholar
  8. Martin, D.F., Porter, E.A., Fischer, J.J. and Rockwell, S., 1987, Effect of a perfluorochemical emulsion on the radiation response of BA1112 rhabdomyosarcomas. Radiat. Res., 112: 45.PubMedCrossRefGoogle Scholar
  9. Riess, J.G. and Le Blanc, M., 1982, Solubility and transport phenomena in perfluorochemicals relevant to blood substitution and other biomedical applications. Pure Appl. Chem., 54: 2383.CrossRefGoogle Scholar
  10. Rockwell, S., Irvin, C.G. and Kelley, M., 1988, Preclinical studies of a perfluorochemical emulsion as an adjunct to radiotherapy. Int. J. Radia. Oncol. Biol. Phys., 15: 913.CrossRefGoogle Scholar
  11. Rose, C. Lustig, R., Mcintosh, N. and Teicher, B., 1986, A clinical trial of Fluosol-DA 20% in advanced squamous cell carcinoma of the head and neck. Int. J. Radia. Oncol. Biol. Phys., 12: 1325.CrossRefGoogle Scholar
  12. Sharma, S.K., Bollands, A.D., Davis, S.S. and Lowe, K.C., 1987, Emulsified perfluorochemicals as physiological oxygen transport fluids: assessment of a novel formulation, in: “Oxygen Transport to Tissue”, Vol. IX, I.A. Silver and A. Silver, eds., p. 97, Plenum, London.Google Scholar
  13. Sharma, S.K., Lowe, K.C. and Davis, S.S., 1988, Novel compositions of emulsified perfluorochemicals for biological uses. Biomat. Art. Cells Art. Org., 16: 447.Google Scholar
  14. Snedecor, G.W. and Cochran, W.G., 1980, “Statistical Methods”, 7th Edn., Iowa State College Press, Ames.Google Scholar
  15. Song, C.W., Zhang, W.L., Pence, D.M., Lee, I. and Levitt, S.H., 1985, Increased radiosensitivity of tumors by perfluorochemicals and carbogen. Int. J. Radiat. Oncol. Biol. Phys., 11: 1833.PubMedCrossRefGoogle Scholar
  16. Teicher, B.A. and Holden, S.A., 1987, Survey of the effect of adding Fluosol-DA 20%/oxygen to treatment with various chemotherapeutic agents. Cancer Treatment Rep., 71: 173.Google Scholar

Copyright information

© Plenum Press, New York 1990

Authors and Affiliations

  • M. C. Berenbaum
    • 1
    • 2
    • 3
  • S. L. Akande
    • 1
    • 2
    • 3
  • F. H. Armstrong
    • 1
    • 2
    • 3
  • P. K. Bentley
    • 1
    • 2
    • 3
  • R. Bonnett
    • 1
    • 2
    • 3
  • R. D. White
    • 1
    • 2
    • 3
  • K. C. Lowe
    • 1
    • 2
    • 3
  1. 1.Dept. PathologySt. Mary’s Hospital Medical SchoolLondonUK
  2. 2.Dept. ZoologyUniversity of NottinghamNottinghamUK
  3. 3.Dept. ChemistryQueen Mary CollegeLondonUK

Personalised recommendations